saplin

Kotak Healthcare Fund

Kotak Healthcare Fund (Direct, Growth): saplin Score 9.5/10 (Strong) among 126 Sectoral/Thematic funds. 1Y return 32.9%, expense ratio 0.99%. Returns that beat most peers, with nothing standing out as a weakness. NAV ₹18.64 on 11 Nov 2026.

Loading the full analysis…

Questions about Kotak Healthcare Fund

What is the expense ratio of Kotak Healthcare Fund?

The Direct plan's total expense ratio is 0.99% a year, against a median of 1.20% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages Kotak Healthcare Fund?

Dhananjay Tikariha (since 11 Dec 2023); Abhishek Bisen (since 11 Dec 2023).

What are the top holdings of Kotak Healthcare Fund?

Sun Pharmaceutical Industries 13.42%, Divis Laboratories 10.23%, Ami Organics 4.88%, Molbio Diagnostics 4.74%, Torrent Pharmaceuticals 4.29% of the portfolio, as of 31 Oct 2026.

What returns has Kotak Healthcare Fund given?

1 year: 32.9% (category median 4.6%). Past returns do not predict future ones.

How big is Kotak Healthcare Fund?

About ₹743 cr (AMFI's average for the latest quarter).

How does Kotak Healthcare Fund score?

9.5 out of 10 (Strong) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.